Francesco Sola

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity

Alessia Montagnoli, Barbara Valsasina, Valter Croci et al. · Nature Chemical Biology · 2008 · 215 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase

Riccardo Colombo, Marina Caldarelli, Milena Mennecozzi et al. · Cancer Research · 2010 · 201 citations · Full text

Medicine, Cancer Biology, Oncology +17

PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity

Chiara Soncini, Patrizia Carpinelli, Laura Gianellini et al. · Clinical Cancer Research · 2006 · 161 citations

Medicine, Oncology, Pharmacology +16

Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1<i>H</i>-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy

Gianluca Papeo, Helena Posteri, Daniela Borghi et al. · Journal of Medicinal Chemistry · 2015 · 143 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Cdc7 Inhibition Reveals a p53-Dependent Replication Checkpoint That Is Defective in Cancer Cells

Alessia Montagnoli, Pierluigi Tenca, Francesco Sola et al. · Cancer Research · 2004 · 140 citations · Full text

Life Sciences, Cell Biology, Oncology +17